81 filings
Page 4 of 5
10-Q/A
3b20idh15vjv7uezkes
16 Aug 21
Quarterly report (amended)
8:01am
10-Q
tcgjv6y kyockb
12 Aug 21
Quarterly report
8:53am
8-K
51bxnigu
12 Aug 21
Verve Therapeutics Announces Business and Program Highlights and Reports Second Quarter 2021 Financial Results
8:20am
8-K
0r4dsgqfg1ey
21 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:06pm
S-8
9ysotwdp
17 Jun 21
Registration of securities for employees
4:54pm
424B4
adbn 2bsoj9m65voc
17 Jun 21
Prospectus supplement with pricing info
4:50pm
EFFECT
ol5bajuvq74yjnokfpqq
17 Jun 21
Notice of effectiveness
12:15am
S-1MEF
vcar sa9acnlc6gsqsi
16 Jun 21
Registration of additional securities for an S-1
6:57pm
SEC STAFF
enyfnqln16 rxe81z
16 Jun 21
SEC staff action: Order
12:00am
CERT
h3tedr25uqw 7lq
15 Jun 21
Certification of approval for exchange listing
11:16am
S-1/A
cmbh 1ft5wm91yehaoqr
14 Jun 21
IPO registration (amended)
6:15am
CORRESP
v4zhslki
14 Jun 21
Correspondence with SEC
12:00am
CORRESP
lcb5xfth2982iqivjd6v
14 Jun 21
Correspondence with SEC
12:00am
8-A12B
gzlstid yly
11 Jun 21
Registration of securities on exchange
4:16pm
CORRESP
frqakl12fkoyhna8c
4 Jun 21
Correspondence with SEC
12:00am
S-1
jshoaj
28 May 21
IPO registration
4:04pm
CORRESP
0raszrr0gxo8hasli
28 May 21
Correspondence with SEC
12:00am
SEC STAFF
2jv5r6bu
13 May 21
SEC staff action: Order
12:00am
UPLOAD
z0cqc
13 May 21
Letter from SEC
12:00am
DRS
s8dzw9t3
16 Apr 21
Draft registration statement
12:00am